Latest filing published 20 Nov 2023 for Acura Pharmaceuticals, INC.
No signal scores available.
This profile gathers the share dealings of Robert A. Seiser in Acura Pharmaceuticals, Inc. We count 3 filings; the first trade dates from 3 August 2022 and the latest from 20 November 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 20 November 2023, the filings show an option exercise in Acura Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations